Brief: Climb Bio Reports Fourth Quarter And Year-End 2024 Financial Results And Provides Business Updates
March 25 (Reuters) - Climb Bio Inc CLYM.O: CLIMB BIO REPORTS FOURTH QUARTER AND YEAR-END 2024 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATES CLIMB BIO INC - EXPECTS CASH RUNWAY THROUGH 2027 CLIMB BIO INC: QTRLY LOSS PER SHARE $0.13 Source text: ID:nGNX3b6NF6 Further company coverage: CLYM.O ((Reuters.Briefs@thomsonreuters.com;))